Bucciol, G., Delafontaine, S., Segers, H., Bossuyt, X., Hershfield, M. S., Moens, L., & Meyts, I. (2017). Hematopoietic Stem Cell Transplantation in ADA2 Deficiency: Early Restoration of ADA2 Enzyme Activity and Disease Relapse upon Drop of Donor Chimerism. J Clin Immunol, 37(8), 746–750. https://doi.org/10.1007/s10875-017-0449-8

Bucciol, Giorgia, Selket Delafontaine, Heidi Segers, Xavier Bossuyt, Michael S. Hershfield, Leen Moens, and Isabelle Meyts. “Hematopoietic Stem Cell Transplantation in ADA2 Deficiency: Early Restoration of ADA2 Enzyme Activity and Disease Relapse upon Drop of Donor Chimerism.” J Clin Immunol 37, no. 8 (November 2017): 746–50. https://doi.org/10.1007/s10875-017-0449-8.

Bucciol G, Delafontaine S, Segers H, Bossuyt X, Hershfield MS, Moens L, et al. Hematopoietic Stem Cell Transplantation in ADA2 Deficiency: Early Restoration of ADA2 Enzyme Activity and Disease Relapse upon Drop of Donor Chimerism. J Clin Immunol. 2017 Nov;37(8):746–50.

Bucciol, Giorgia, et al. “Hematopoietic Stem Cell Transplantation in ADA2 Deficiency: Early Restoration of ADA2 Enzyme Activity and Disease Relapse upon Drop of Donor Chimerism.” J Clin Immunol, vol. 37, no. 8, Nov. 2017, pp. 746–50. Pubmed, doi:10.1007/s10875-017-0449-8.

Bucciol G, Delafontaine S, Segers H, Bossuyt X, Hershfield MS, Moens L, Meyts I. Hematopoietic Stem Cell Transplantation in ADA2 Deficiency: Early Restoration of ADA2 Enzyme Activity and Disease Relapse upon Drop of Donor Chimerism. J Clin Immunol. 2017 Nov;37(8):746–750.